Can a wrinkle injection smooth away the signs of aging?

NCT ID NCT06385171

Terminated Symptom relief Sponsor: Global Aesthetics LLC Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial investigates whether botulinum toxin type A, commonly known as Botox, can safely reduce facial wrinkles. Adults aged 20 to 65 with forehead or frown-line wrinkles will receive injections, and doctors will assess changes using visual and photographic scales. The study aims to determine if this treatment is effective and well-tolerated for cosmetic wrinkle reduction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Botulinum toxin type A (also known as OnabotulinumtoxinA), injected into facial wrinkles
What this could lead to: If successful, this could provide a safe, effective option for reducing facial wrinkles and improving appearance.
What could go wrong: This is an early-stage trial with a small number of participants. Results may not apply to everyone, and side effects like redness or inflammation can occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WRINKLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WRINKLE

Contacts and locations

Locations

Global Aesthetics LLC

Cisco, Texas, 76437, United States
Global Aesthetics LLC

Lubbock, Texas, 79413, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.